Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shandong Pharmaceutical Glass Co., Ltd
  6. News
  7. Summary
    600529   CNE000001BG9

SHANDONG PHARMACEUTICAL GLASS CO., LTD

(600529)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Shandong Pharmaceutical Glass Co., Ltd announced that it expects to receive CNY 1.8664947 billion in funding

09/07/2021 EST

Shandong Pharmaceutical Glass Co., Ltd announced a private placement of not more than 178,490,324 class A shares for gross proceeds of not more than CNY 1,866,494,700 on September 7, 2021. The transaction will include participation from no more than 35 specific subscribers including securities investment fund management companies, securities companies, trust investment companies, financial companies, insurance institutional investors, and qualified foreign institutional investors, other qualified domestic legal person investors and natural persons. The issue price shall be not be lower than 80% of the average price of the company’s stock trading on the 20 trading days prior to the pricing base date. The shares to be issued shall have a hold period of 6 months from the closing of the transaction. The transaction has been approved at the ninth session of the ninth board of supervisors and 14th meeting of the 9th board of directors of the company. The transaction still needs to be approved by the shareholders of the company, competent state-owned assets supervision and management department or its authorized body, Zibo State-owned Assets Supervision and Administration Commission, and China Securities Regulatory Commission. The validity period of resolution is 12 months from the date of review and approval by the shareholders of the company.


ę S&P Capital IQ 2021
All news about SHANDONG PHARMACEUTICAL GLASS CO., LTD
2021SHANDONG PHARMACEUTICAL GLASS CO., L : 600529) added to Shanghai Stock Exchange Health Car..
CI
2021Shandong Pharmaceutical Glass Co., Ltd announced that it expects to receive CNY 1.86649..
CI
2021Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended..
CI
2021Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Fourth Quarter ..
CI
2020Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months End..
CI
2020SHANDONG PHARMACEUTICAL GLASS CO., L : 600529) added to FTSE All-World Index
CI
2020SHANDONG PHARMACEUTICAL GLASS CO., L : 600529) added to S&P Global BMI Index
CI
2020Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended..
CI
2020Shandong Pharmaceutical Glass Co., Ltd Announces Cash Dividend for the Year 2019, Payab..
CI
2020Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter E..
CI
More news
Financials
Sales 2021 3 977 M 629 M 629 M
Net income 2021 665 M 105 M 105 M
Net cash 2021 1 417 M 224 M 224 M
P/E ratio 2021 31,0x
Yield 2021 1,07%
Capitalization 20 598 M 3 259 M 3 259 M
EV / Sales 2021 4,82x
EV / Sales 2022 4,18x
Nbr of Employees -
Free-Float 77,7%
Chart SHANDONG PHARMACEUTICAL GLASS CO., LTD
Duration : Period :
Shandong Pharmaceutical Glass Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANDONG PHARMACEUTICAL GLASS CO., LTD
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 34,62 CNY
Average target price 42,86 CNY
Spread / Average Target 23,8%
EPS Revisions
Managers and Directors
Jun Zhang General Manager & Director
Yi Zhao Song Chief Financial Officer & Director
Wen Chai Chairman-Supervisory Board
Yong Gang Hu Chairman
Hong Cai Independent Director